Angela Angjelova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Angela Angjelova has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Gaetano Isola
Department of General Surgery and Surgical-Medical Specialties, School of Dentistry, University of Catania, 95123 Catania, Italy
15 shared publications - Alessandro Polizzi
Department of General Surgery and Surgical-Medical Specialties, School of Dentistry, University of Catania, 95123 Catania, Italy
13 shared publications - Elena Jovanova
Unit of Periodontology, Department of General Surgery and Surgical-Medical Specialties, School of Dentistry, University of Catania, 95123 Catania, Italy
12 shared publications - Marco Annunziata
Multidisciplinary Department of Medical-Surgical and Dental Specialties, University of Campania “Luigi Vanvitelli”, 81100 Naples, Italy
4 shared publications - Roberto Campagna
Department for the Promotion of Human Science and Quality of Life, San Raffaele Roma University, Via di Val Cannuta, 247, 00166 Rome, Italy
3 shared publications - Simona Santonocito
Department of Biomedical and Dental Sciences, Morphological and Functional Images, University of Messina, G. Martino Polyclinic, Messina, Italy
3 shared publications
Latest Publications
- Open Access
- 23 October 2026
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 48 (11) , 1105
Single-Cell and Spatial Omics of the Oral Cancer Ecosystem: A Scoping Review and Translational Evidence Map from Malignant Transformation to Immunotherapy Response
Background/Objectives: Oral squamous cell carcinoma (OSCC) and oral potentially malignant disorders (OPMDs) exhibit marked cellular and spatial heterogeneity that is incompletely captured by bulk molecular profiling. This scoping review mapped single-cell and spatial omics applications across oral carcinogenesis and assessed the translational maturity of reported biomarkers and signatures. Methods: MEDLINE via PubMed, Scopus, and Web of Science were searched in August 2026. Human studies of OPMDs and OSCC using eligible single-cell or spatial omics were selected according to a predefined PCC framework and synthesized following JBI and PRISMA-ScR guidance. Biomarkers were classified using a prespecified, review-specific exploratory T0–T4 Translational Maturity Matrix. Results: Of 1405 records identified, 735 duplicates were removed, 670 records screened, and 64 full texts assessed; 55 studies were included. Single-cell RNA sequencing was used in 49/55 studies (89.1%), while 20/55 (36.4%) incorporated spatial omics. Recurrent themes included epithelial plasticity, fibroblast and immune remodeling, spatially organized metabolic and stromal niches, nodal dissemination, and treatment-associated immune reconfiguration. One study was T0, four T1, 27 T2, and 23 T3. T3 reflected validation in an independent patient cohort or external dataset linked to a clinical endpoint, rather than validation of a clinically qualified assay. No study reached T4. Conclusions: Single-cell and spatial omics have refined the oral cancer ecosystem, but clinical translation remains limited by platform heterogeneity, overlapping datasets, and insufficient prospective validation; the maturity framework should therefore be interpreted as an exploratory evidence-mapping tool rather than a validated measure of clinical readiness. Standardized longitudinal studies and clinically deployable assays are needed to advance precision oral oncology.
- 23 October 2026
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 48 (11) , 1105
Open AccessSingle-Cell and Spatial Omics of the Oral Cancer Ecosystem: A Scoping Review and Translational Evidence Map from Malignant Transformation to Immunotherapy Response
Background/Objectives: Oral squamous cell carcinoma (OSCC) and oral potentially malignant disorders (OPMDs) exhibit marked cellular and spatial heterogeneity that is incompletely captured by bulk molecular profiling. This scoping review mapped single-cell and spatial omics applications across oral carcinogenesis and assessed the translational maturity of reported biomarkers and signatures. Methods: MEDLINE via PubMed, Scopus, and Web of Science were searched in August 2026. Human studies of OPMDs and OSCC using eligible single-cell or spatial omics were selected according to a predefined PCC framework and synthesized following JBI and PRISMA-ScR guidance. Biomarkers were classified using a prespecified, review-specific exploratory T0–T4 Translational Maturity Matrix. Results: Of 1405 records identified, 735 duplicates were removed, 670 records screened, and 64 full texts assessed; 55 studies were included. Single-cell RNA sequencing was used in 49/55 studies (89.1%), while 20/55 (36.4%) incorporated spatial omics. Recurrent themes included epithelial plasticity, fibroblast and immune remodeling, spatially organized metabolic and stromal niches, nodal dissemination, and treatment-associated immune reconfiguration. One study was T0, four T1, 27 T2, and 23 T3. T3 reflected validation in an independent patient cohort or external dataset linked to a clinical endpoint, rather than validation of a clinically qualified assay. No study reached T4. Conclusions: Single-cell and spatial omics have refined the oral cancer ecosystem, but clinical translation remains limited by platform heterogeneity, overlapping datasets, and insufficient prospective validation; the maturity framework should therefore be interpreted as an exploratory evidence-mapping tool rather than a validated measure of clinical readiness. Standardized longitudinal studies and clinically deployable assays are needed to advance precision oral oncology.
- Open Access
- 7 September 2026
- Published by IMR Press in Frontiers in Bioscience-Landmark
- Vol. 31 (9)
From Inflamed Gingiva to Invasive Malignancy: Molecular Crosstalk in Oral Carcinogenesis: A Scoping Review
Oral squamous cell carcinoma (OSCC) develops within a complex inflammatory microenvironment where chronic mucosal inflammation and microbial dysbiosis may contribute to malignant transformation. Increasing evidence suggests that periodontal pathogens associated with chronic gingival inflammation can influence epithelial signaling, immune responses, and tumor progression. This scoping review aimed to map current molecular, genomic, and immunological evidence linking chronic gingival inflammation and periodontal pathogen–associated dysbiosis to OSCC. Following the Population-Concept-Context (PCC) framework, electronic searches were conducted in PubMed, Scopus, and Web of Science through February 2026. Original studies investigating mechanistic links between periodontal inflammation, microbial dysbiosis, and OSCC in human samples, in vitro models, or animal models were included. Data were extracted on microbial drivers, oncogenic signaling pathways, immune modulation, and genomic or epigenetic alterations. A total of 46 studies were included, suggesting that periodontal pathogens, particularly Porphyromonas gingivalis and Fusobacterium nucleatum, may activate oncogenic signaling pathways such as NF-κB, PI3K/Akt, Wnt/β-catenin, and TGF-β. Evidence from in vitro, animal, and human studies indicates that these pathways may contribute to epithelial-mesenchymal transition (EMT), tumor invasion, and resistance to apoptosis. Microbial exposure has also been associated with modulation of the tumor immune microenvironment, including macrophage polarization, suppression of cytotoxic T-cell responses, and enhanced immune checkpoint signaling. In addition, genomic and transcriptomic studies have identified dysregulated genes and microRNAs associated with inflammation-driven carcinogenesis. Overall, chronic gingival inflammation and periodontal dysbiosis appear to contribute to OSCC development through interconnected mechanisms involving inflammatory and cytokine signalling, microbe sensing and innate immune activation, immune suppression and tumor immune escape, EMT, invasion and metastatic signaling, and metabolic reprogramming with regulatory networks. However, as current evidence is largely derived from in vitro and animal studies with limited prospective clinical data, well-designed longitudinal human studies are needed to confirm these associations and support biomarkers discovery and novel preventive or therapeutic strategies targeting early oncogenic events in inflamed oral tissues.
- 7 September 2026
- Published by IMR Press in Frontiers in Bioscience-Landmark
- Vol. 31 (9)
Open AccessFrom Inflamed Gingiva to Invasive Malignancy: Molecular Crosstalk in Oral Carcinogenesis: A Scoping Review
Oral squamous cell carcinoma (OSCC) develops within a complex inflammatory microenvironment where chronic mucosal inflammation and microbial dysbiosis may contribute to malignant transformation. Increasing evidence suggests that periodontal pathogens associated with chronic gingival inflammation can influence epithelial signaling, immune responses, and tumor progression. This scoping review aimed to map current molecular, genomic, and immunological evidence linking chronic gingival inflammation and periodontal pathogen–associated dysbiosis to OSCC. Following the Population-Concept-Context (PCC) framework, electronic searches were conducted in PubMed, Scopus, and Web of Science through February 2026. Original studies investigating mechanistic links between periodontal inflammation, microbial dysbiosis, and OSCC in human samples, in vitro models, or animal models were included. Data were extracted on microbial drivers, oncogenic signaling pathways, immune modulation, and genomic or epigenetic alterations. A total of 46 studies were included, suggesting that periodontal pathogens, particularly Porphyromonas gingivalis and Fusobacterium nucleatum, may activate oncogenic signaling pathways such as NF-κB, PI3K/Akt, Wnt/β-catenin, and TGF-β. Evidence from in vitro, animal, and human studies indicates that these pathways may contribute to epithelial-mesenchymal transition (EMT), tumor invasion, and resistance to apoptosis. Microbial exposure has also been associated with modulation of the tumor immune microenvironment, including macrophage polarization, suppression of cytotoxic T-cell responses, and enhanced immune checkpoint signaling. In addition, genomic and transcriptomic studies have identified dysregulated genes and microRNAs associated with inflammation-driven carcinogenesis. Overall, chronic gingival inflammation and periodontal dysbiosis appear to contribute to OSCC development through interconnected mechanisms involving inflammatory and cytokine signalling, microbe sensing and innate immune activation, immune suppression and tumor immune escape, EMT, invasion and metastatic signaling, and metabolic reprogramming with regulatory networks. However, as current evidence is largely derived from in vitro and animal studies with limited prospective clinical data, well-designed longitudinal human studies are needed to confirm these associations and support biomarkers discovery and novel preventive or therapeutic strategies targeting early oncogenic events in inflamed oral tissues.
- Open Access
- 16 July 2026
- Published by MDPI AG in Metabolites
- Vol. 16 (7) , 502
Metagenomics in the Interplay Among Oral and Gut Dysbiosis
Periodontitis is a chronic inflammatory disease increasingly recognized as a manifestation of complex microbial dysbiosis extending beyond the oral cavity. Recent advances in spatial metagenomics provide unprecedented resolution to investigate microbial community structure, function, and localization within periodontal niches and along the oral–gut axis. This review aims to explore how spatially resolved metagenomic approaches refine our understanding of the ecological and functional shifts in bacterial populations associated with periodontitis and their systemic implications. By integrating spatial mapping with shotgun metagenomics, we highlight distinct microenvironmental signatures within periodontal pockets, characterized by anaerobic pathobionts, metabolic reprogramming, and localized inflammatory gradients. Furthermore, we examine evidence supporting bidirectional interactions between oral and gut microbiota, suggesting that oral-derived taxa may contribute to gut dysbiosis through translocation and ecological disruption. From a basic science perspective, spatial metagenomics reveals niche-specific microbial functions and interspecies interactions that are not captured by bulk sequencing. Clinically, these insights open avenues for precision diagnostics and targeted therapeutics, including microbiome modulation strategies tailored to spatial microbial organization. Overall, this work underscores the importance of spatial context in metagenomic analyses and advances the conceptual framework linking periodontal disease to systemic microbial dysbiosis.
- 16 July 2026
- Published by MDPI AG in Metabolites
- Vol. 16 (7) , 502
Open AccessMetagenomics in the Interplay Among Oral and Gut Dysbiosis
Periodontitis is a chronic inflammatory disease increasingly recognized as a manifestation of complex microbial dysbiosis extending beyond the oral cavity. Recent advances in spatial metagenomics provide unprecedented resolution to investigate microbial community structure, function, and localization within periodontal niches and along the oral–gut axis. This review aims to explore how spatially resolved metagenomic approaches refine our understanding of the ecological and functional shifts in bacterial populations associated with periodontitis and their systemic implications. By integrating spatial mapping with shotgun metagenomics, we highlight distinct microenvironmental signatures within periodontal pockets, characterized by anaerobic pathobionts, metabolic reprogramming, and localized inflammatory gradients. Furthermore, we examine evidence supporting bidirectional interactions between oral and gut microbiota, suggesting that oral-derived taxa may contribute to gut dysbiosis through translocation and ecological disruption. From a basic science perspective, spatial metagenomics reveals niche-specific microbial functions and interspecies interactions that are not captured by bulk sequencing. Clinically, these insights open avenues for precision diagnostics and targeted therapeutics, including microbiome modulation strategies tailored to spatial microbial organization. Overall, this work underscores the importance of spatial context in metagenomic analyses and advances the conceptual framework linking periodontal disease to systemic microbial dysbiosis.
- Open Access
- 15 July 2026
- Published by MDPI AG in Microorganisms
- Vol. 14 (7) , 1551
Revisiting the Oral–Gut Axis: Microbial Symbiosis, Dysbiosis, and Bidirectional Links Between Periodontitis and Inflammatory Bowel Disease
Background: Recent scientific evidence indicates that the oral–gut axis represents a critical interface in host–microbiota interactions, carrying profound implications for both periodontal and gastrointestinal diseases. This scoping review aims to evaluate the reciprocal influence between periodontitis and inflammatory bowel disease (IBD). Specifically, the underlying mechanisms of microbial translocation, immune interaction, and metabolite-mediated signaling linking the oral microbiota to gut microbial ecology are critically evaluated. Methods: Studies were selected from the PubMed, Web of Science, and Scopus databases up to May 2026. Eligible criteria included in vivo studies written in English and conducted within the last 10 years, whereas human studies involving participants under 18 years of age were excluded. The included studies analyze the effects of oral and gut dysbiosis on the opposing district. Through the database search, 2094 records were identified, and 34 articles were selected based on the eligibility criteria. Results: The included studies demonstrate the interconnection between the oral and gut microbiota. The included studies reveal that predominant oral taxa, specifically Porphyromonas gingivalis, Fusobacterium nucleatum, and Aggregatibacter actinomycetemcomitans, alter intestinal microbial composition. In particular, P. gingivalis colonizes the gut, exacerbating both oral and intestinal inflammation by stimulating pro-inflammatory cytokine expression via Th17 cell activation. Finally, salivary microbial composition appears to be associated with the presence and status of IBD. Conclusions: Understanding these interconnected microbial ecosystems provides valuable insights that may support the future development of integrated diagnostic and therapeutic strategies for patients suffering from periodontitis and IBD. Further large-scale studies with longer follow-up periods are required to standardize potential salivary markers and multidisciplinary therapeutic protocols for the management of periodontitis and IBD.
- 15 July 2026
- Published by MDPI AG in Microorganisms
- Vol. 14 (7) , 1551
Open AccessRevisiting the Oral–Gut Axis: Microbial Symbiosis, Dysbiosis, and Bidirectional Links Between Periodontitis and Inflammatory Bowel Disease
Background: Recent scientific evidence indicates that the oral–gut axis represents a critical interface in host–microbiota interactions, carrying profound implications for both periodontal and gastrointestinal diseases. This scoping review aims to evaluate the reciprocal influence between periodontitis and inflammatory bowel disease (IBD). Specifically, the underlying mechanisms of microbial translocation, immune interaction, and metabolite-mediated signaling linking the oral microbiota to gut microbial ecology are critically evaluated. Methods: Studies were selected from the PubMed, Web of Science, and Scopus databases up to May 2026. Eligible criteria included in vivo studies written in English and conducted within the last 10 years, whereas human studies involving participants under 18 years of age were excluded. The included studies analyze the effects of oral and gut dysbiosis on the opposing district. Through the database search, 2094 records were identified, and 34 articles were selected based on the eligibility criteria. Results: The included studies demonstrate the interconnection between the oral and gut microbiota. The included studies reveal that predominant oral taxa, specifically Porphyromonas gingivalis, Fusobacterium nucleatum, and Aggregatibacter actinomycetemcomitans, alter intestinal microbial composition. In particular, P. gingivalis colonizes the gut, exacerbating both oral and intestinal inflammation by stimulating pro-inflammatory cytokine expression via Th17 cell activation. Finally, salivary microbial composition appears to be associated with the presence and status of IBD. Conclusions: Understanding these interconnected microbial ecosystems provides valuable insights that may support the future development of integrated diagnostic and therapeutic strategies for patients suffering from periodontitis and IBD. Further large-scale studies with longer follow-up periods are required to standardize potential salivary markers and multidisciplinary therapeutic protocols for the management of periodontitis and IBD.
- Top Cited PapersOpen Access
- 1 April 2026
- Published by Wiley in Periodontology 2000
- Vol. 99 (1) , 284-310
Impact and efficacy of systemic antibiotics for peri‐implant diseases treatment: A systematic review and meta‐analysis on clinical and microbiological outcomes
Aim: To evaluate the adjunctive effects of systemic antibiotics (SA) on clinical and microbiological outcomes in the treatment of peri‐implant diseases. Materials and Methods: A systematic review and meta‐analysis were conducted following PRISMA guidelines and registered on PROSPERO (CRD420251059056). Randomized and non‐randomized clinical trials evaluating SA as adjuncts to non‐surgical treatment of peri‐implant mucositis (PM) and to non‐surgical or surgical therapy of peri‐implantitis (PI) were included. Rob2 and MINORS tools were used to assess the risk of bias of included articles. Results: Eighteen studies were included in the qualitative analysis, of which only nine randomized clinical trials met the criteria for quantitative analysis. For PM treatment, SA did not significantly affect any assessed clinical outcomes (p>0.05). For PI treatment, the meta‐analysis showed that, in both non‐surgical and surgical PI treatment, adjunctive SA resulted in a significant bleeding on probing reduction at 12 months (p=0.007) and a significant probing pocket depth reduction at 12 months (p=0.004). However, no significant improvements in marginal bone level (MBL) were observed. For antimicrobial outcomes, only 2 studies reported significant effects of metronidazole as an adjunct to treatment on reductions in P. gingivalis and T. forsythia up to 12 months. Conclusions: SA do not provide additional clinical or microbiological benefits in the treatment of PM. In PI, adjunctive systemic antibiotics may offer only limited improvements in selected clinical outcomes and specific peri‐implant pathogens for up to 12 months, without consistent benefits on MBL. However, given the heterogeneity of the available evidence, further high‐quality, long‐term studies are needed.
- 1 April 2026
- Published by Wiley in Periodontology 2000
- Vol. 99 (1) , 284-310
Top Cited PapersOpen AccessImpact and efficacy of systemic antibiotics for peri‐implant diseases treatment: A systematic review and meta‐analysis on clinical and microbiological outcomes
Aim: To evaluate the adjunctive effects of systemic antibiotics (SA) on clinical and microbiological outcomes in the treatment of peri‐implant diseases. Materials and Methods: A systematic review and meta‐analysis were conducted following PRISMA guidelines and registered on PROSPERO (CRD420251059056). Randomized and non‐randomized clinical trials evaluating SA as adjuncts to non‐surgical treatment of peri‐implant mucositis (PM) and to non‐surgical or surgical therapy of peri‐implantitis (PI) were included. Rob2 and MINORS tools were used to assess the risk of bias of included articles. Results: Eighteen studies were included in the qualitative analysis, of which only nine randomized clinical trials met the criteria for quantitative analysis. For PM treatment, SA did not significantly affect any assessed clinical outcomes (p>0.05). For PI treatment, the meta‐analysis showed that, in both non‐surgical and surgical PI treatment, adjunctive SA resulted in a significant bleeding on probing reduction at 12 months (p=0.007) and a significant probing pocket depth reduction at 12 months (p=0.004). However, no significant improvements in marginal bone level (MBL) were observed. For antimicrobial outcomes, only 2 studies reported significant effects of metronidazole as an adjunct to treatment on reductions in P. gingivalis and T. forsythia up to 12 months. Conclusions: SA do not provide additional clinical or microbiological benefits in the treatment of PM. In PI, adjunctive systemic antibiotics may offer only limited improvements in selected clinical outcomes and specific peri‐implant pathogens for up to 12 months, without consistent benefits on MBL. However, given the heterogeneity of the available evidence, further high‐quality, long‐term studies are needed.
- Open Access
The Association of Periodontitis with Circadian Rhythm Disorders and Sleep—A Scoping Review
Background and Objectives: This scoping review aims to assess the correlation between periodontitis, circadian rhythm disorders, and sleep quality. Materials and Methods: This review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) guidelines to identify eligible studies from the following databases: PubMed, Scopus, and Web of Science. The research question was formulated as follows: “What is the evidence about the correlation between periodontitis, circadian rhythm disorders and sleep?”. Results: Through database searching, 1673 records were identified, and ultimately, 20 studies were included. Among these, seven articles were about the correlation between circadian rhythm and periodontitis; thirteen articles discussed the association between sleep and periodontitis. Conclusions: Circadian rhythm alterations and poor sleep are related to periodontitis. A causal relationship between circadian rhythm disturbances, poor sleep, and periodontitis remains unclear, especially because of the cross-sectional design of most studies. No study has conducted an analysis of the reverse causality. To clarify this correlation, longitudinal studies should be conducted. A few experiments suggested that circadian rhythm disturbances and sleep deprivation induce periodontitis. Assessing direct causality and understanding the precise role of circadian rhythm alterations and sleep quality on periodontitis can lead to personalizing the management of the condition.
Open AccessThe Association of Periodontitis with Circadian Rhythm Disorders and Sleep—A Scoping Review
Background and Objectives: This scoping review aims to assess the correlation between periodontitis, circadian rhythm disorders, and sleep quality. Materials and Methods: This review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) guidelines to identify eligible studies from the following databases: PubMed, Scopus, and Web of Science. The research question was formulated as follows: “What is the evidence about the correlation between periodontitis, circadian rhythm disorders and sleep?”. Results: Through database searching, 1673 records were identified, and ultimately, 20 studies were included. Among these, seven articles were about the correlation between circadian rhythm and periodontitis; thirteen articles discussed the association between sleep and periodontitis. Conclusions: Circadian rhythm alterations and poor sleep are related to periodontitis. A causal relationship between circadian rhythm disturbances, poor sleep, and periodontitis remains unclear, especially because of the cross-sectional design of most studies. No study has conducted an analysis of the reverse causality. To clarify this correlation, longitudinal studies should be conducted. A few experiments suggested that circadian rhythm disturbances and sleep deprivation induce periodontitis. Assessing direct causality and understanding the precise role of circadian rhythm alterations and sleep quality on periodontitis can lead to personalizing the management of the condition.
- Top Cited PapersOpen Access
- 25 February 2026
- Published by MDPI AG in Bioengineering
- Vol. 13 (3) , 263
Present and Future of the Use of Artificial Intelligence in Orthodontics
Artificial intelligence (AI) has penetrated many aspects of orthodontic clinical practice over the past decade. This narrative review aims to highlight all the areas where AI has already entered clinical routine and how it can further improve orthodontic practice in the future. AI is present in diagnostic procedures, facilitating record keeping and supporting the study of patient radiographic and photographic image characteristics. It also underpins the creation and analysis of digital impressions. AI has also become part of patient communication processes, helping to share treatment decisions and facilitating treatment monitoring. Technology and the availability of clinical data also enable the use of AI in diagnostic processes. Currently, clinicians must evaluate AI-provided clinical suggestions before accepting them, as is the case with clear aligner treatments, for example. Research on AI in dentistry, reported in this article, promises to increase the precision of diagnostic measurements and facilitate clinicians’ treatment decisions.
- 25 February 2026
- Published by MDPI AG in Bioengineering
- Vol. 13 (3) , 263
Top Cited PapersOpen AccessPresent and Future of the Use of Artificial Intelligence in Orthodontics
Artificial intelligence (AI) has penetrated many aspects of orthodontic clinical practice over the past decade. This narrative review aims to highlight all the areas where AI has already entered clinical routine and how it can further improve orthodontic practice in the future. AI is present in diagnostic procedures, facilitating record keeping and supporting the study of patient radiographic and photographic image characteristics. It also underpins the creation and analysis of digital impressions. AI has also become part of patient communication processes, helping to share treatment decisions and facilitating treatment monitoring. Technology and the availability of clinical data also enable the use of AI in diagnostic processes. Currently, clinicians must evaluate AI-provided clinical suggestions before accepting them, as is the case with clear aligner treatments, for example. Research on AI in dentistry, reported in this article, promises to increase the precision of diagnostic measurements and facilitate clinicians’ treatment decisions.
- Open Access
Impact of Periodontal Host-Modulation Therapies on Oral–Gut Microbiome Axis in Periodontitis Patients with Hematological Diseases: A Narrative Review
Host-modulating therapies and oral microbiome-targeted approaches are emerging options in periodontal care and are especially relevant for patients undergoing immunotherapy for hematologic malignancies. Immune dysregulation induced by immune checkpoint inhibitors or CAR-T cell therapy may worsen periodontal inflammation and alter the composition and functions of the oral microbiota. Beyond these, other immunomodulatory treatments commonly employed in hematologic malignancies—including monoclonal antibodies (e.g., rituximab, daratumumab), immunomodulatory drugs (e.g., lenalidomide, thalidomide), cytokine-based therapies (e.g., interferon-α), and targeted small-molecule inhibitors (e.g., BTK inhibitors, JAK inhibitors) may also influence periodontal homeostasis and oral microbial ecology by altering neutrophil function, cytokine profiles, and mucosal immune surveillance. The oral microbiota is functionally connected with the intestinal microbial ecosystem through the oral–gut axis, by periodontal pathogens may colonize the gut and modulate systemic immune responses, with potential repercussions on the efficacy and safety of immunotherapy. This narrative review examines the mechanisms and clinical applicability of host-modulating therapies, including subantimicrobial-dose doxycycline, omega-3 fatty acids, and microbiome-targeted interventions, such as oral probiotics, prebiotics and other antimicrobials in patients treated with immunotherapy.
Open AccessImpact of Periodontal Host-Modulation Therapies on Oral–Gut Microbiome Axis in Periodontitis Patients with Hematological Diseases: A Narrative Review
Host-modulating therapies and oral microbiome-targeted approaches are emerging options in periodontal care and are especially relevant for patients undergoing immunotherapy for hematologic malignancies. Immune dysregulation induced by immune checkpoint inhibitors or CAR-T cell therapy may worsen periodontal inflammation and alter the composition and functions of the oral microbiota. Beyond these, other immunomodulatory treatments commonly employed in hematologic malignancies—including monoclonal antibodies (e.g., rituximab, daratumumab), immunomodulatory drugs (e.g., lenalidomide, thalidomide), cytokine-based therapies (e.g., interferon-α), and targeted small-molecule inhibitors (e.g., BTK inhibitors, JAK inhibitors) may also influence periodontal homeostasis and oral microbial ecology by altering neutrophil function, cytokine profiles, and mucosal immune surveillance. The oral microbiota is functionally connected with the intestinal microbial ecosystem through the oral–gut axis, by periodontal pathogens may colonize the gut and modulate systemic immune responses, with potential repercussions on the efficacy and safety of immunotherapy. This narrative review examines the mechanisms and clinical applicability of host-modulating therapies, including subantimicrobial-dose doxycycline, omega-3 fatty acids, and microbiome-targeted interventions, such as oral probiotics, prebiotics and other antimicrobials in patients treated with immunotherapy.
- Top Cited PapersOpen Access
- 7 November 2025
- Published by Wiley in Journal of Periodontology
- Vol. 97 (3) , 435-449
Effectiveness of two supportive periodontal care protocols and outcome predictors during periodontitis: A randomized controlled trial
Background: A randomized, controlled trial was conducted to evaluate the effectiveness of two supportive periodontal care (SPC) approaches in patients with periodontitis and to evaluate possible predictors influencing bleeding on probing (BoP) changes at 24‐month follow‐up. Methods: Fifty‐six periodontitis patients who first received active periodontal treatment by means of quadrant‐wise subgingival instrumentation were subsequently assigned to either a control group (oral hygiene instruction with supragingival instrumentation and dental polishing, n = 28) or a test group (oral hygiene instruction with both supra‐ and subgingival instrumentation and dental polishing, n = 28). BoP was the primary outcome, and probing pocket depth (PPD), clinical attachment level (CAL), full‐mouth plaque score (FMPS), gingival bleeding index (GBI), and the number of pocket sites were secondary outcome measures, recorded up to 24 months of follow‐up. A mixed generalized linear regression analysis also assessed the potential confounding factors that influenced BoP changes at 24 months. Results: At 24 months, both groups showed significant improvement in periodontal outcomes ( p < 0.05). The test intervention was more effective than the control in reducing median BoP ( p = 0.033), GBI ( p = 0.023), the number of pockets ≥4 mm with BoP ( p = 0.018), 4–5 mm ( p = 0.048), 5–6 mm ( p = 0.011), and >6 mm ( p = 0.023). Among all follow‐up sessions, the reduced BoP was significantly negatively influenced by the number of median PPD ( p = 0.031), the number of pockets 4–5 mm ( p = 0.029), PPD 5–6 mm ( p = 0.036), smoking ( p = 0.039), and by the number of cigarettes/day ( p = 0.042) and positively by test treatment ( p = 0.033). Conclusion: SPC that included subgingival instrumentation yielded better results than the control to reduce BoP at 24‐month follow‐up. Smoking and deep pockets negatively influenced the BoP reduction in patients who underwent SPC. Plain Language Summary: Supportive periodontal care (SPC) is a series of individualized, site‐specific treatments aimed at preventing periodontitis recurrence/progression after successful completion of active periodontal therapy. SPC approaches performed by means of oral hygiene instruction with supra‐ and subgingival instrumentation and dental polishing (test group) compared to oral hygiene with supragingival instrumentation alone and dental polishing (control group) were both effective in reducing median periodontal outcomes, such as bleeding on probing (BoP), probing pocket depth (PPD), clinical attachment level (CAL), and full‐mouth plaque score (FMPS) after active periodontal treatment. However, the SPC approach that included subgingival instrumentation yielded better results compared to oral prophylaxis alone in reducing BoP, a parameter that was significantly influenced also by smoking, median PPD, a high number of sites with PPD 4–5 mm, 5–6 mm, and no sites >6 mm at 24‐month follow‐up.
- 7 November 2025
- Published by Wiley in Journal of Periodontology
- Vol. 97 (3) , 435-449
Top Cited PapersOpen AccessEffectiveness of two supportive periodontal care protocols and outcome predictors during periodontitis: A randomized controlled trial
Background: A randomized, controlled trial was conducted to evaluate the effectiveness of two supportive periodontal care (SPC) approaches in patients with periodontitis and to evaluate possible predictors influencing bleeding on probing (BoP) changes at 24‐month follow‐up. Methods: Fifty‐six periodontitis patients who first received active periodontal treatment by means of quadrant‐wise subgingival instrumentation were subsequently assigned to either a control group (oral hygiene instruction with supragingival instrumentation and dental polishing, n = 28) or a test group (oral hygiene instruction with both supra‐ and subgingival instrumentation and dental polishing, n = 28). BoP was the primary outcome, and probing pocket depth (PPD), clinical attachment level (CAL), full‐mouth plaque score (FMPS), gingival bleeding index (GBI), and the number of pocket sites were secondary outcome measures, recorded up to 24 months of follow‐up. A mixed generalized linear regression analysis also assessed the potential confounding factors that influenced BoP changes at 24 months. Results: At 24 months, both groups showed significant improvement in periodontal outcomes ( p < 0.05). The test intervention was more effective than the control in reducing median BoP ( p = 0.033), GBI ( p = 0.023), the number of pockets ≥4 mm with BoP ( p = 0.018), 4–5 mm ( p = 0.048), 5–6 mm ( p = 0.011), and >6 mm ( p = 0.023). Among all follow‐up sessions, the reduced BoP was significantly negatively influenced by the number of median PPD ( p = 0.031), the number of pockets 4–5 mm ( p = 0.029), PPD 5–6 mm ( p = 0.036), smoking ( p = 0.039), and by the number of cigarettes/day ( p = 0.042) and positively by test treatment ( p = 0.033). Conclusion: SPC that included subgingival instrumentation yielded better results than the control to reduce BoP at 24‐month follow‐up. Smoking and deep pockets negatively influenced the BoP reduction in patients who underwent SPC. Plain Language Summary: Supportive periodontal care (SPC) is a series of individualized, site‐specific treatments aimed at preventing periodontitis recurrence/progression after successful completion of active periodontal therapy. SPC approaches performed by means of oral hygiene instruction with supra‐ and subgingival instrumentation and dental polishing (test group) compared to oral hygiene with supragingival instrumentation alone and dental polishing (control group) were both effective in reducing median periodontal outcomes, such as bleeding on probing (BoP), probing pocket depth (PPD), clinical attachment level (CAL), and full‐mouth plaque score (FMPS) after active periodontal treatment. However, the SPC approach that included subgingival instrumentation yielded better results compared to oral prophylaxis alone in reducing BoP, a parameter that was significantly influenced also by smoking, median PPD, a high number of sites with PPD 4–5 mm, 5–6 mm, and no sites >6 mm at 24‐month follow‐up.
- Open Access
- 8 August 2025
- Published by MDPI AG in Antibiotics
- Vol. 14 (8) , 815
Effects of Antiseptic Formulations on Oral Microbiota and Related Systemic Diseases: A Scoping Review
Background: Oral antiseptic formulations are widely used as adjuncts in oral hygiene to reduce pathogenic microorganisms and prevent oral diseases. While these agents are effective in controlling biofilm, their broader effects may disrupt the oral microbiota’s balance, potentially contributing to systemic health implications. The complex relationship between antiseptic use, microbial composition, and systemic outcomes remains insufficiently mapped. Objective: This scoping review aimed to explore and map the current evidence regarding the impact of antiseptic formulations on oral microbiota composition and to examine their potential associations with systemic diseases. Methods: A comprehensive literature search was performed using PubMed, Scopus, and Web of Science up to June 2025. Studies were included if they investigated antiseptic formulations commonly used in oral healthcare—such as chlorhexidine, essential oils, and cetylpyridinium chloride—and reported effects on oral microbiota and/or systemic health. Eligible study types included human clinical trials, observational studies, in vitro, and animal studies. Two reviewers independently screened and selected studies, with disagreements resolved by consensus. Data extraction focused on study design, antiseptic agents, microbial outcomes, and systemic implications. A total of 12 studies were included and charted. Results: The included studies demonstrated that oral antiseptics effectively reduce pathogenic microorganisms and improve clinical outcomes in oral diseases such as gingivitis and periodontitis. However, several studies also reported alterations in commensal microbial communities, suggesting a potential for dysbiosis. Some studies indicated possible links between antiseptic-induced microbial changes and systemic conditions, including cardiovascular and respiratory diseases. Conclusions: The evidence highlights a dual effect of antiseptic formulations: while beneficial in controlling oral pathogens, they may disrupt microbial homeostasis with possible systemic consequences. Further research is needed to evaluate long-term effects and develop targeted, microbiota-preserving oral hygiene strategies.
- 8 August 2025
- Published by MDPI AG in Antibiotics
- Vol. 14 (8) , 815
Open AccessEffects of Antiseptic Formulations on Oral Microbiota and Related Systemic Diseases: A Scoping Review
Background: Oral antiseptic formulations are widely used as adjuncts in oral hygiene to reduce pathogenic microorganisms and prevent oral diseases. While these agents are effective in controlling biofilm, their broader effects may disrupt the oral microbiota’s balance, potentially contributing to systemic health implications. The complex relationship between antiseptic use, microbial composition, and systemic outcomes remains insufficiently mapped. Objective: This scoping review aimed to explore and map the current evidence regarding the impact of antiseptic formulations on oral microbiota composition and to examine their potential associations with systemic diseases. Methods: A comprehensive literature search was performed using PubMed, Scopus, and Web of Science up to June 2025. Studies were included if they investigated antiseptic formulations commonly used in oral healthcare—such as chlorhexidine, essential oils, and cetylpyridinium chloride—and reported effects on oral microbiota and/or systemic health. Eligible study types included human clinical trials, observational studies, in vitro, and animal studies. Two reviewers independently screened and selected studies, with disagreements resolved by consensus. Data extraction focused on study design, antiseptic agents, microbial outcomes, and systemic implications. A total of 12 studies were included and charted. Results: The included studies demonstrated that oral antiseptics effectively reduce pathogenic microorganisms and improve clinical outcomes in oral diseases such as gingivitis and periodontitis. However, several studies also reported alterations in commensal microbial communities, suggesting a potential for dysbiosis. Some studies indicated possible links between antiseptic-induced microbial changes and systemic conditions, including cardiovascular and respiratory diseases. Conclusions: The evidence highlights a dual effect of antiseptic formulations: while beneficial in controlling oral pathogens, they may disrupt microbial homeostasis with possible systemic consequences. Further research is needed to evaluate long-term effects and develop targeted, microbiota-preserving oral hygiene strategies.